课题基金 / 基金详情

METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE

METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
甲基苯丙胺毒性和皮质纹状体谷氨酸
批准号:
6191387
负责人:
Bryan K Yamamoto
金额:
$32.69万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-07-15 至 2005-05-31

项目摘要

项目成果

Bryan K Yamamoto的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人摘要):冰毒滥用有所增加 自20世纪80年代末以来,整个美国以惊人的速度增长。S。人类研究 大脑和临床前研究表明,单一或重复的 服用冰毒会导致脑多巴胺的长期耗尽 (DA)脑内与DA神经传递有关的含量和其他标志物 锥体外系运动系统。尽管有这些发现,但 冰毒对多巴胺神经元的中介毒性尚不清楚。最近, 谷氨酸被认为是脑多巴胺损伤的重要介质 冰毒产生的系统,但这些变化背后的机制 谷氨酸能活动,最终导致“兴奋性毒性”,并损害 黑质纹状体DA系统尚未阐明。 这项研究的总体目标是确定神经通路 (锥体外区运动环)和调节强化纹状体的突起 冰毒后产生长期DA耗竭的谷氨酸能活动 行政管理。谷氨酸可导致兴奋性毒性、氧化性 压力,以及受损的生物能量学是众所周知的。因此,关键是 锥体外环在冰毒诱导的皮质纹状体中的作用 谷氨酸的释放和由此导致的受损的细胞过程 纹状体,表现为自由基损伤,细胞能量受损,以及 兴奋性毒性也将被评估。最重要的假设是 冰毒诱导的纹状体长期DA耗竭部分是由于增强 皮质纹状体谷氨酸升高所介导的细胞外谷氨酸 溢出来了。具体地说,皮质纹状体谷氨酸释放的增加是由 通过多突触机制涉及:(1)纹状体黑质GABA能 传递,(2)丘脑GABA释放减少,(3)增加 谷氨酸在皮质中的释放。此外,兴奋性毒性标记物--血影蛋白 蛋白质分解,以及氧化和代谢应激指数将评估 冰毒后皮质纹状体谷氨酸释放增加的后果。这个 拟议中的实验的独特之处在于,它们将开始解决冰毒是如何, 通过激活基底节回路,增加皮质纹状体 谷氨酸传递产生兴奋性毒性,损害细胞能量, 氧化应激,并最终损害纹状体DA终末。总的来说, 这些实验对结果具有重要的临床意义。 冰毒滥用者的兴奋性毒性,并提示可能存在相似之处 冰毒所致神经毒性与帕金森病的病理生理关系 疾病。
英文摘要
DESCRIPTION (applicant's abstract): Methamphetamine (METH) abuse has increased across the U.S. at an alarming rate since the late 1980's. Studies on human brain and preclinical studies have revealed that the single or repeated administration of METH results in a long-lasting depletion of brain dopamine (DA) content and other markers associated with DA neurotransmission in the extrapyramidal motor system. Despite these findings, the mechanisms that mediate toxicity to DA neurons following METH remain unknown. Recently, glutamate has been implicated as an important mediator of damage to brain DA systems produced by METH, but the mechanisms underlying the changes in glutamatergic activity that culminate in "excitotoxicity" and damage the nigrostriatal DA system have yet to be elucidated. The overall objective of this study is to identify the neural pathways (extrapyramidal motor loops) and processes that mediate enhanced striatal glutamatergic activity to produce long-term DA depletions after METH administration. The fact that glutamate can lead to excitotoxicity, oxidative stress, and compromised bioenergetics is well known. Therefore, the critical role of the extrapyramidal circuitry in mediating METH-induced corticostriatal glutamate release and the resultant compromised cellular processes in the striatum as evidenced by free radical damage, impaired cellular energetics, and excitotoxicity also will be assessed. The overarching hypothesis is that METH-induced long-term DA depletions in the striatum are due partly to enhanced extracellular glutamate mediated by increased corticostriatal glutamate overflow. Specifically, increased corticostriatal glutamate release is mediated by multisynaptic mechanisms involving (1) increased striatonigral GABAergic transmission, (2) decreased GABA release in thalamus, and (3) increased glutamate release in cortex. Furthermore, the excitotoxic marker, spectrin proteolysis, and indices of oxidative and metabolic stress will assess the consequences of increased corticostriatal glutamate release following METH. The proposed experiments are unique in that they will begin to address how METH, via the activation of the basal ganglia circuitry, increases corticostriatal glutamate transmission to produce excitotoxicity, impaired cellular energetics, oxidative stress, and ultimately damage to striatal DA terminals. Overall, these experiments have significant clinical implications for the consequences of excitotoxicity in METH abusers and are suggestive of possible parallels between METH-induced neurotoxicity and the pathophysiology of Parkinson's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Methamphetamine-Alcohol Interactions and Mechanisms of Augmented Toxicity to Brain and Peripheral Organs
Methamphetamine, Stress and Brain Endothelium
Methamphetamine, Stress and Brain Endothelium
Methamphetamine, Stress and Brain Endothelium
海外基金